Follow
Davide Bedognetti
Davide Bedognetti
Verified email at sidra.org
Title
Cited by
Cited by
Year
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
42862018
The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures
J Galon, HK Angell, D Bedognetti, FM Marincola
Immunity 39 (1), 11-26, 2013
8672013
Toward nanotechnology-enabled approaches against the COVID-19 pandemic
C Weiss, M Carriere, L Fusco, I Capua, JA Regla-Nava, M Pasquali, ...
ACS nano 14 (6), 6383-6406, 2020
5412020
BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis
R Roychoudhuri, K Hirahara, K Mousavi, D Clever, CA Klebanoff, ...
Nature 498 (7455), 506-510, 2013
4162013
Evolution of metastases in space and time under immune selection
M Angelova, B Mlecnik, A Vasaturo, G Bindea, T Fredriksen, L Lafontaine, ...
Cell 175 (3), 751-765. e16, 2018
3732018
NY-ESO-1 based immunotherapy of cancer: current perspectives
R Thomas, G Al-Khadairi, J Roelands, W Hendrickx, S Dermime, ...
Frontiers in immunology 9, 947, 2018
3702018
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
SN Lone, S Nisar, T Masoodi, M Singh, A Rizwan, S Hashem, W El-Rifai, ...
Molecular cancer 21 (1), 79, 2022
2952022
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer
A Thomas, ED Routh, A Pullikuth, G Jin, J Su, JW Chou, KA Hoadley, ...
Oncoimmunology 7 (10), e1490854, 2018
1972018
Functionalized multiwalled carbon nanotubes as ultrasound contrast agents
LG Delogu, G Vidili, E Venturelli, C Ménard-Moyon, MA Zoroddu, G Pilo, ...
Proceedings of the National Academy of Sciences 109 (41), 16612-16617, 2012
1572012
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
D Bedognetti, TL Spivey, Y Zhao, L Uccellini, S Tomei, ME Dudley, ...
British journal of cancer 109 (9), 2412-2423, 2013
1472013
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis
W Hendrickx, I Simeone, S Anjum, Y Mokrab, F Bertucci, P Finetti, ...
Oncoimmunology 6 (2), e1253654, 2017
1452017
A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily
A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ...
Cell systems 7 (4), 422-437. e7, 2018
1422018
Immunogenomic classification of colorectal cancer and therapeutic implications
J Roelands, PJK Kuppen, L Vermeulen, C Maccalli, J Decock, E Wang, ...
International journal of molecular sciences 18 (10), 2229, 2017
1402017
Impact of carbon nanotubes and graphene on immune cells
M Orecchioni, D Bedognetti, F Sgarrella, FM Marincola, A Bianco, ...
Journal of translational medicine 12, 1-11, 2014
1342014
Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in patients with cancer
C Vernieri, G Fucà, F Ligorio, V Huber, A Vingiani, F Iannelli, A Raimondi, ...
Cancer Discovery 12 (1), 90-107, 2022
1312022
Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells
M Orecchioni, D Bedognetti, L Newman, C Fuoco, F Spada, W Hendrickx, ...
Nature communications 8 (1), 1109, 2017
1312017
Functionalized carbon nanotubes as immunomodulator systems
M Pescatori, D Bedognetti, E Venturelli, C Ménard-Moyon, C Bernardini, ...
Biomaterials 34 (18), 4395-4403, 2013
1292013
Photodynamic therapy based on graphene and MXene in cancer theranostics
A Gazzi, L Fusco, A Khan, D Bedognetti, B Zavan, F Vitale, A Yilmazer, ...
Frontiers in bioengineering and biotechnology 7, 295, 2019
1212019
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
ML Ascierto, MO Idowu, Y Zhao, H Khalak, KK Payne, XY Wang, ...
Journal of translational medicine 11, 1-11, 2013
1112013
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin’s lymphoma patients treated with rituximab-containing regimens
D Bedognetti, G Zoppoli, C Massucco, E Zanardi, S Zupo, A Bruzzone, ...
The Journal of Immunology 186 (10), 6044-6055, 2011
1112011
The system can't perform the operation now. Try again later.
Articles 1–20